NGMBIO
"NGMBIO" is a word and design mark owned by NGM Biopharmaceuticals, Inc., filed at the USPTO on September 23, 2026. It is under examination and covers classes 5, 42 and 44.
- Status
- Under examination
- Since September 23, 2026
- Filed
- September 23, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50124240
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 3 classes
Who owns NGMBIO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
NGM Biopharmaceuticals, Inc.
South San Francisco, United States
Representative
Anna E. Raimer
Jones Day
What the mark covers
The products and services NGMBIO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment and prevention of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Providing medical information in the field of cancer, retinal diseases and liver and metabolic diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About NGMBIO
Who owns the trademark "NGMBIO"?
The USPTO trademark "NGMBIO" (application 50124240) is owned by NGM Biopharmaceuticals, Inc.
What is the status of "NGMBIO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull NGMBIO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0d38f-96c8-731d-93dd-71e7634dd774
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0d38f-96c8-731d-93dd-71e7634dd774",
"object": "trademark",
"mark_text": "NGMBIO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50124240",
"filing_date": "2026-09-23",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "NGM Biopharmaceuticals, Inc.",
"entity_id": "ent_019eb709-1501-71c8-a41f-3b3693f9ceb8"
}
]
}